CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 73 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $322,000 | -51.4% | 274,820 | +1.6% | 0.00% | -100.0% |
| Q4 2015 | $663,000 | -17.8% | 270,444 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $807,000 | -27.4% | 269,027 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $1,112,000 | +2038.5% | 269,221 | +2153.1% | 0.00% | – |
| Q1 2015 | $52,000 | +79.3% | 11,949 | +21.9% | 0.00% | – |
| Q4 2014 | $29,000 | -14.7% | 9,799 | -5.0% | 0.00% | – |
| Q3 2014 | $34,000 | +36.0% | 10,313 | +4.1% | 0.00% | – |
| Q2 2014 | $25,000 | – | 9,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |